The role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
about
Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesEarly administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesLate (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infantsInhaled steroids for neonatal chronic lung diseaseEarly administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesIncreased versus standard energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/ chronic lung diseaseIncreased energy intake for preterm infants with (or developing) bronchopulmonary dysplasia/chronic lung diseaseInhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonatesGender differences in respiratory symptoms in 19-year-old adults born pretermEarly administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates.Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia.Lung function outcome in children of premature birth.Inhaled glucocorticoid therapy in infants at risk for neonatal chronic lung disease.Postnatal glucocorticosteroid therapy for treatment and prevention of neonatal chronic lung disease.Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).Bronchopulmonary dysplasia (chronic lung disease of infancy): an update for the pediatrician.Volume-targeted ventilation is more suitable than pressure-limited ventilation for preterm infants: a systematic review and meta-analysis.Aberrant signaling pathways of the lung mesenchyme and their contributions to the pathogenesis of bronchopulmonary dysplasiaGenetic Contributions to the Development of Complications in Preterm Newborns.NICU bedside caregivers sustain process improvement and decrease incidence of bronchopulmonary dysplasia in infants < 30 weeks gestation.Congenital and perinatal cytomegalovirus lung infection.Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by Ureaplasma urealyticum in macrophages.The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks' gestation.Lung Function and Bronchial Hyperresponsiveness in Adults Born Prematurely. A Cohort Study.The role of corticosteroids in respiratory diseases of children.Human lung growth: a review.Bronchopulmonary dysplasia: pre- and postnatal influences and outcome.Markers and mediators of inflammation in neonatal lung disease.Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats.Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats.Effects of antenatal colonization with ureaplasma urealyticum on pulmonary disease in the immature baboon.Impaired glucocorticoid synthesis in premature infants developing chronic lung disease.Intratracheal budesonide supplementation in addition to surfactant improves pulmonary outcome in surfactant-depleted newborn piglets.Influence of partial liquid ventilation on bacterial growth and alveolar expansion in newborn rabbits with group B-streptococcal pneumonia.Italian survey of neonatal respiratory support strategies.Postnatal betamethasone vs dexamethasone in premature infants with bronchopulmonary dysplasia: a pilot study.Correlation of augmented IL-8 production to premature chronic lung disease: implication of posttranscriptional regulation.Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis.Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
P2860
Q24197850-5D456CE6-3B58-4645-9AD1-45A665795A81Q24197860-4CA1070A-A8D5-4410-8604-1D504D979A33Q24200447-71D39990-85D2-4C3B-834C-9CC63CA06A58Q24241091-3A3B8BD0-EEAF-4713-B478-C95CDF93E971Q24243622-CD25E2D2-F04F-4282-8125-8D7955F6A883Q24245356-985806EB-1816-4AAC-AB65-9795388C4A0EQ24245471-C70E8C4C-8D9D-4BDE-804C-45260ECB43CCQ24250182-BD80B8A5-4C66-46F8-83C2-F3751BD5B486Q24810687-DD974512-B5A7-4F8F-9937-D014394572F7Q30239811-F6127D53-1677-4D33-A10E-23F319A60A79Q31443523-707CC763-6039-4690-8EEF-4949CEC09CD4Q33817245-AA60FC59-BABC-4747-B9E8-C4BBF775A0CCQ34074045-4716E77D-1716-4272-B872-ABED3F130898Q34074665-77A1F631-CEC7-4304-976F-82FE6FDB05C7Q34187223-62EEAB6B-2B65-4B6F-869F-69F21B7B31B7Q34586484-47B1C240-34D0-4F6E-8EB4-7E6D0D48BA0BQ35052958-7E97B0A9-CC27-47F3-94AC-D127928A13BFQ35667226-9760CEC9-5EB8-4C85-B35C-84321114B39AQ35690660-B14B43B7-C51D-4C4C-9C43-711F256F6CB4Q35781072-223E6F91-1655-4F76-AF7D-8C6E17118973Q38097501-D89CBD78-33CB-4A52-B3A1-35AAEC076929Q38610849-07AC7D49-FCEB-4DA5-B8A7-B02452D79CE5Q39517474-BACD150C-D402-46D0-82C9-F5B743EC12D5Q39850779-62F0BDE4-B14F-4A79-8700-B6FE30016CCDQ40368260-68E5E91D-CDBD-41EB-A509-771F653C7698Q41151318-DCB95AE1-1DA5-4688-8BF2-37A0C90A0C76Q41223664-33F52C3A-6B2F-4C72-982A-F932E2251271Q41379025-9D26081C-B345-4AAC-8658-748A6300F0C7Q41462532-DDB4E210-F98C-434E-9391-07FD99676A48Q43277466-BAC052B2-0234-46F7-B761-171163F6DF32Q43660336-FE24BF30-9DDF-4F04-BC8F-1DB3CD4478B6Q43668549-D4E02378-88D0-4F76-B8C9-D006597F584AQ43690537-2D65D860-0FB5-4B67-B49D-20B609A7B53BQ44383842-69C3ED3E-E584-48A3-A5C1-1052B2AD7025Q44557713-56BADB6B-9C4B-48F5-A439-0DF001E23BD3Q45287304-EC1B28DB-F429-423D-A542-D36A8D2C9B73Q46217179-DC5EB591-E67B-4DF5-A963-2F4948716BEEQ46639407-23223C2F-8C64-475F-8609-2DAA21B4BB20Q47145768-4727F794-E1BD-4E02-A154-8857238E06B1Q47181565-2D6DFDD3-DFAA-4119-9F38-E9BEDCAADE11
P2860
The role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
The role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
@en
type
label
The role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
@en
prefLabel
The role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
@en
P2860
P921
P356
P1476
The role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
@en
P2093
Bancalari E
P2860
P304
P356
10.1002/PPUL.1950190611
P577
1995-06-01T00:00:00Z